Prothena reported 109.53M in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -14.32M 28.46M
Adamas Pharmaceuticals ADMS:US -5502000 3.51M
Agios Pharmaceuticals AGIO:US $ -88.94M 0.07M
Akebia Therapeutics AKBA:US $ -45.4M 24.43M
Alexion Pharmaceuticals ALXN:US $ 892.3M 186.4M
ALKERMES ALKS:US $ -0.27M 23.16M
Alnylam Pharmaceuticals ALNY:US $ -169.89M 35.54M
Amgen AMGN:US $ 3228M 40M
Biogen BIIB:US $ 991.8M 155.8M
Biomarin Pharmaceutical BMRN:US $ -9.16M 48.05M
Bluebird Bio BLUE:US $ -190.8M 44.05M
Exelixis EXEL:US $ 56.42M 70.25M
Gw Pharmaceuticals GWPH:US $ -17.18M 2.02M
Intercept Pharmaceuticals ICPT:US $ -5.41M 6.8M
Intra Cellular Therapies ITCI:US $ -77.19M 8.17M
Macrogenics MGNX:US $ -50191000 12.69M
Nektar Therapeutics NKTR:US $ -109.98M 3.32M
Neurocrine Biosciences NBIX:US $ 47.3M 23.1M
Prothena PRTA:US 109.53M 81.29M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M
Seattle Genetics SGEN:US $ -281.36M 207.58M
Ultragenyx Pharmaceutical RARE:US $ -86.61M 6.96M
Vertex Pharmaceuticals VRTX:US $ 1087.41M 1092.53M
Xoma XOMA:US $ -3343000 281K
YTE INCY:US $ 262.16M 92.39M